- ►diabetesjournals.org NH White, HP Chase, S Arslanian, WV … - Diabetes Care, 2009 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—Continuous glucose monitoring data were collected
from a subset of patients (n = 90) who agreed to use a continuous glucose
monitoring system during an active-controlled, randomized, open-label study ... Related articles - All 5 versions
HP Chase, S Arslanian, NH White, WV … - The Journal of Pediatrics, 2008 - Elsevier The overall mean change in A1C from baseline to week 24 was similar in the 2
groups: insulin glargine (n = 76), −0.25% ± 0.14%; NPH/Lente (n = 81), 0.05%
± 0.13% (P = .1725). However, an analysis of covariance, adjusting for ... Cited by 5 - Related articles - All 6 versions
R Fiallo-Scharer… - The Journal of clinical endocrinology and metabolism, 2005 - ncbi.nlm.nih.gov CONTEXT: Advantages/disadvantages of continuous vs. discrete glucose monitoring
are not well documented. OBJECTIVE: Compare glucose profiles from home meters
vs. continuous sensors. DESIGN: Randomized clinical trial conducted by the ... Cited by 7 - Related articles - All 2 versions
HHH Feringa, SE Karagiannis, R Vidakovic, A … - Annals of Vascular Surgery, 2007 - Elsevier Glycemic control may be an underestimated risk factor in diabetic patients with
peripheral arterial disease (PAD). Chronic statin therapy may improve glycemic
control and outcome in these patients. In an observational cohort study of ... Cited by 3 - Related articles - BL Direct - All 39 versions
[CITATION] Less variability in blood glucose values with insulin glargine vs intermediate-acting insulin …
NH White, W Tamborlane, K Usiskin - Program and abstracts of the American Diabetes … Cited by 3 - Related articles
DJ Cox, L Gonder-Frederick, L Ritterband, W … - Diabetes Care, 2007 - Am Diabetes Assoc RESULTS—Relative risk for SH, quantified by the ratio of an individual's low
blood glucose index (LBGI) based on the previous 150 SMBG readings to the LBGI
based on recent SMBG readings, increased significantly in the 24 h before ... Cited by 13 - Related articles - BL Direct - All 5 versions
PE Cryer - EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY …, 2001 - thieme-connect.com Hypoglycemia is the limiting factor in the glycemic management of diabetes
because it generally precludes maintenance of euglycemia. Improving glycemic
control while minimizing hypoglycemia in type 1 diabetes mellitus (T1DM) ... Cited by 14 - Related articles - BL Direct - All 4 versions
[CITATION] The Diabetes Research in Children Network (DirecNet) Study Group. Accuracy of the …
AC Moses, P Raskin, N Khutoryansky - Diabetic Medicine, 2008 - pt.wkhealth.com Results: Baseline 1,5-AG was low and not significantly different (4.9 ± 3.5 and
4.3 ± 2.6 μg/ml in the BIAsp 30 and IGlar groups, respectively). After 28
weeks, the levels of 1,5-AG were higher in the BIAsp 30 than in the IGlar ... Cited by 2 - Related articles - BL Direct - All 4 versions
SE Siegelaar, W Kulik, H van Lenthe, R … - Diabetes Obes Metab, 2009 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 1 - Related articles - All 2 versions
